Skip to main content

Peer Review reports

From: A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol

Original Submission
22 Apr 2016 Submitted Original manuscript
18 Jul 2016 Author responded Author comments - Jacek Hajda
Resubmission - Version 2
18 Jul 2016 Submitted Manuscript version 2
2 Jan 2017 Reviewed Reviewer Report - Jean Baptiste Bachet
20 Feb 2017 Reviewed Reviewer Report - Anne M Noonan
27 Mar 2017 Author responded Author comments - Jacek Hajda
Resubmission - Version 3
27 Mar 2017 Submitted Manuscript version 3
3 Apr 2017 Reviewed Reviewer Report - Anne M Noonan
26 Jun 2017 Author responded Author comments - Jacek Hajda
Resubmission - Version 4
26 Jun 2017 Submitted Manuscript version 4
Publishing
24 Aug 2017 Editorially accepted
29 Aug 2017 Article published 10.1186/s12885-017-3604-y

You can find further information about peer review here.

Back to article page